Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
70.98
+0.87 (1.24%)
Jan 22, 2026, 11:58 AM EST - Market open
Haemonetics Employees
Haemonetics had 3,023 employees as of March 29, 2025. The number of employees decreased by 634 or -17.34% compared to the previous year.
Employees
3,023
Change (1Y)
-634
Growth (1Y)
-17.34%
Revenue / Employee
$439,249
Profits / Employee
$55,637
Market Cap
3.32B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 29, 2025 | 3,023 | -634 | -17.34% |
| Mar 30, 2024 | 3,657 | 623 | 20.53% |
| Apr 1, 2023 | 3,034 | 213 | 7.55% |
| Apr 2, 2022 | 2,821 | 113 | 4.17% |
| Apr 3, 2021 | 2,708 | -296 | -9.85% |
| Mar 28, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 1, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Integer Holdings | 11,000 |
| QuidelOrtho | 6,600 |
| UFP Technologies | 4,146 |
| LivaNova | 2,900 |
| iRhythm Holdings | 2,000 |
| Artivion | 1,600 |
| Inspire Medical Systems | 1,246 |
| Establishment Labs Holdings | 1,018 |
HAE News
- 8 days ago - Haemonetics Corporation (HAE) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - GlobeNewsWire
- 13 days ago - Vivasure Medical Announces Acquisition by Haemonetics Corporation - Business Wire
- 13 days ago - Haemonetics Acquires Vivasure Medical Limited - PRNewsWire
- 14 days ago - Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026 - PRNewsWire
- 20 days ago - Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 22 days ago - Earn Twice The Yield You Get From Bank On HAE Stock - Forbes
- 7 weeks ago - Top 2 Health Care Stocks You May Want To Dump This Month - Benzinga